Modeling and Simulation Archives

White Paper

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Replace or waive TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA.…

CertaraOctober 3, 2025

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Blog

Best Practices in Clinical Pharmacology Gap Analysis

September 19, 2025 Submitting your New Drug Application (NDA) to the FDA is the ultimate…

CertaraSeptember 19, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

CertaraSeptember 4, 2025

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

CertaraSeptember 3, 2025

On-Demand Webinar

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…

CertaraAugust 29, 2025

Conference

BioTechX US 2025

– – Booth

Simona ColucciAugust 15, 2025

Modeling and Simulation

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Best Practices in Clinical Pharmacology Gap Analysis

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Redefining Every Stage of Investment (RESI) Seed to Exit

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

BioTechX US 2025

Newsletter sign up

Quick links

Solutions

Contact